bit.bio has today launched a new product, ioSkeletal Myocytes. It’s the first product of its kind that provides physiologically relevant human skeletal muscle cells that are reliable, reproducible and ...
CAMBRIDGE, England--(BUSINESS WIRE)--bit.bio, the company coding human cells for novel cures, today launches its first set of muscle cell disease model products designed to advance the discovery and ...